CDD-1819 structure
|
Common Name | CDD-1819 | ||
|---|---|---|---|---|
| CAS Number | 2894104-40-4 | Molecular Weight | 553.65 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C35H31N5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CDD-1819CDD-1819 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 5 nM. CDD-1819 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1]. |
| Name | CDD-1819 |
|---|
| Description | CDD-1819 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 5 nM. CDD-1819 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1]. |
|---|---|
| Related Catalog | |
| Target |
Ki: 5 nM (SARS-CoV-2 Mpro)[1] |
| References |
| Molecular Formula | C35H31N5O2 |
|---|---|
| Molecular Weight | 553.65 |
| InChIKey | YXZCMQAWBHCPMS-HTFLBPPUSA-N |
| SMILES | CNC(=O)C1CC(n2c(-c3cncc4ccccc34)nc3cccc(C(=O)NC(C)c4ccc5ccccc5c4)c32)C1 |